Doxorubicin hydrochloride and Descovy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 6 people who take Doxorubicin hydrochloride and Descovy. Common interactions include abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people who take Doxorubicin hydrochloride and Descovy have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 21, 2023

6 people who take Doxorubicin hydrochloride and Descovy together, and have interactions are studied.


What is Doxorubicin hydrochloride?

Doxorubicin hydrochloride has active ingredients of doxorubicin hydrochloride. Currently, eHealthMe is studying from 22,633 Doxorubicin hydrochloride users.

What is Descovy?

Descovy has active ingredients of emtricitabine; tenofovir alafenamide fumarate. It is used in hiv infection. Currently, eHealthMe is studying from 13,063 Descovy users.

Number of Doxorubicin hydrochloride and Descovy reports submitted per year:

Doxorubicin hydrochloride and Descovy drug interactions.

Common Doxorubicin Hydrochloride and Descovy drug interactions by gender *:

female:

n/a

male:

  1. Abdominal pain upper
  2. Diarrhoea
  3. Dyspnoea
  4. Epigastric discomfort
  5. Glaucoma
  6. Helicobacter test positive
  7. Lung adenocarcinoma
  8. Spinal compression fracture
  9. Kaposi's sarcoma
  10. Vomiting


Common Doxorubicin Hydrochloride and Descovy drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal pain upper
  2. Diarrhoea
  3. Dyspnoea
  4. Epigastric discomfort
  5. Glaucoma
  6. Helicobacter test positive
  7. Lung adenocarcinoma
  8. Spinal compression fracture
  9. Kaposi's sarcoma
  10. Vomiting

* Approximation only. Some reports may have incomplete information.

Do you take Doxorubicin hydrochloride and Descovy?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Drug side effects by duration, gender and age:

Common Doxorubicin hydrochloride drug interactions:

Browse interactions between Doxorubicin hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Descovy drug interactions:

Browse interactions between Descovy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on doxorubicin hydrochloride and emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Doxorubicin hydrochloride and Descovy, respectively), and Doxorubicin hydrochloride and Descovy (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Doxorubicin hydrochloride and Descovy.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: